2rounds
1led
Cybersecurity 1Fintech 1
Series B 1, Series C+ 1
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Valon $150M Series DArmadin $255.5M Series BLoading investors…
Ranked by rounds participated in, from announcements in Sep 6, 2026 – Oct 5, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Valon $150M Series DArmadin $255.5M Series BNew companies 1 · Follow-on 1
Stages: Series B 1, Series C 1
Armadin $255.5M Series BMetaview $60M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Armadin $255.5M Series BRestate $20M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Onomondo Undisclosed Majority investmentEUCLYD >€200M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
EUCLYD >€200M Series ATandem Health $100M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Mama Insurance Undisclosed New funding roundCato €6M SeedNew companies 1 · Follow-on 0
Stages: Undisclosed 1
Blue Health Intelligence €3.4M €3.4 million growth capitalNew companies 1 · Follow-on 0
Stages: Undisclosed 1
Everphone €15M €15 million corporate loan refinancing“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.